Patients with eosinophilic esophagitis (EoE) frequently describe the condition as painful, disruptive, ⁣and ⁤frightening. This ⁣rare, chronic disease causes inflammation of ⁤the⁢ esophagus, leading to symptoms like abdominal pain, difficulty swallowing (dysphagia), vomiting, and, in some cases, food impaction – where food becomes lodged in the throat. ⁤ According to ⁤the American ‍Partnership for Eosinophilic⁢ Disorders, EoE affects ⁤an estimated ⁢1 in 2,000⁣ to 1 in‍ 10,000 people in the United States (American‍ Partnership ⁤for Eosinophilic Disorders, 2024).

Now, a researcher at the University of Cincinnati‍ College of Medicine has ‍received new funding to expand investigations into the ⁤underlying causes of EoE and potential new treatments.

New Research Funding Awarded

Simin Zhang,MD,an allergist and research assistant professor in the Division of ⁣Rheumatology,Allergy and Immunology within the Department of Internal Medicine at the ⁣University ‍of ‍Cincinnati,has been awarded a three-year,$300,000⁤ grant from ⁤the American Academy of Allergy,Asthma ⁢& Immunology (AAAAI) (American Academy of Allergy, Asthma & ‍Immunology, 2024). The grant, awarded on September 9, 2024, will support Dr. Zhang’s research focusing on the roles of ⁤mast cells – a type of allergic immune cell – and their interactions with fibroblasts, the structural cells responsible for tissue repair.

“Manny⁤ people with EoE struggle just to eat a meal without fear,” said Zhang. “Our goal is to uncover the mechanisms driving the disease and ultimately improve therapies so that patients can live more comfortably.”

Understanding the⁤ Role of Mast cells ⁣and Fibroblasts

Dr. Zhang’s research delves into how⁣ mast cells and fibroblasts interact in the esophageal tissue of EoE patients. Fibroblasts, while typically involved in healing, can contribute to⁤ esophageal remodeling and narrowing in EoE.The study aims to understand how mast cell activation influences fibroblast behavior, potentially⁣ leading to new therapeutic targets.

Current treatments for EoE primarily focus on ⁣symptom management, including dietary elimination, proton pump inhibitors (PPIs), and topical corticosteroids. Though,these treatments ⁢aren’t ⁢always effective,and long-term use of⁤ corticosteroids can ⁢have side effects. Identifying the specific mechanisms driving the disease could pave the way for more targeted and effective therapies.

What is Eosinophilic⁤ Esophagitis?

EoE is characterized by a high number of eosinophils – a type of⁤ white blood cell – in the esophagus. These eosinophils release substances that cause inflammation and ⁣damage to the esophageal lining. The exact cause of EoE is unknown, but it’s believed to be a combination of genetic predisposition and environmental factors, often ‍linked to allergies.